Table 1 Enrolled patients’ clinical characteristics and lesion distribution

Age(years)

63.4 ± 13.8

61.2 ± 10.7

63.5 (51.5,70.0)

0.23

Sex

0.22

 Male

19

41

22

 Female

23

25

20

BMI (kg/m²)

17.3 (16.6,17.7)

22.1 (20.8,23.1)

27.5 ± 2.9

<0.001

Blood glucose (mmol/L)

5.9 ± 1.1

5.7 ± 1.3

5.5 (4.8,6.5)

0.54

Injected dose (MBq)

171.1 (163.9,190.2)

223.9 (210.2,243.8)

276.9 ± 41.3

<0.001

Injected dose/weight (MBq/kg)

3.8 ± 0.3

3.8 ± 0.3

3.7 ± 0.2

0.26

Uptake time (min)

68.0 (55.1,79.3)

65.1 (58.7,75.4)

69.5 ± 16.2

0.92

Primary cancer type*

 Bone cancer

0/1

1/1

0/1

 Breast cancer

2/12

6/12

4/12^**

 Cervical cancer

2/5

2/5

1/5

 Colorectal cancer

4/11

2/11^**

5/11

 Duodenal cancer

0/1

1/1

0/1

 Epithelial cancer

1/3

0/3

2/3

 Esophageal cancer

6/23

13/23^**

4/23

 Gastric cancer

6/7^**

1/7

0/7

 Hypopharynx cancer

1/2

1/2

0/2

 Kidney cancer

0/2

2/2

0/2

 Liver cancer

1/3

1/3

1/3

 Lung cancer

11/45

18/45^**

16/45^**

 Lymphoma

3/17

7/17

7/17

 Malignant melanoma

1/2

0/2

1/2

 Nasopharynx cancer

1/6

3/6

2/6

 Ovarian cancer

0/3

3/3

0/3

 Pancreatic cancer

1/6

5/6^**

0/6

 Sarcoma

1/2

1/2

0/2

 Spindle cell tumor

1/1

0/1

0/1

 Squamous cell carcinoma

0/1

1/1

0/1

 Thyroid cancer

1/1^**

0/1

0/1